SAR 5.9
(1.03%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 48.53 Million | 76.73 Million | 91.38 Million | 54.7 Million | -535.5 Million |
Net Income | 35.13 Million | 43.37 Million | -33.83 Million | 1.12 Million | -64.37 Million |
Depreciation & Amortization | 43.53 Million | 43.4 Million | 39.94 Million | 27.29 Million | 20.92 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -26.8 Million | -22.82 Million | -6.39 Million | 11.37 Million | -560.12 Million |
Other non-cash items | 87.61 Million | 12.77 Million | 91.66 Million | 14.9 Million | 68.06 Million |
Investing Cash Flow | -3.24 Million | -2.48 Million | -138.97 Million | -417.56 Million | -507.3 Million |
Investments in PPE | -1.47 Million | -1.11 Million | -658.32 Thousand | - | - |
Acquisitions | - | - | - | - | - |
Investment purchases | -1.76 Million | -1.36 Million | -138.31 Million | -417.56 Million | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | -1.76 Million | -1.36 Million | -138.31 Million | -417.56 Million | -507.3 Million |
Financing Cash Flow | -41.6 Million | -101.79 Million | 54.44 Million | 387.7 Million | 554.77 Million |
Debt repayment | -1.57 Million | -1.57 Million | -1.71 Million | -1.57 Million | -1.57 Million |
Dividends payments | -40.02 Million | -63.52 Million | -54.01 Million | -42.02 Million | -28.3 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | 138.79 Million | 33.8 Million | 237.54 Million |
Other Financing Activities | -20.71 Million | -36.68 Million | -28.62 Million | 397.49 Million | 347.11 Million |
Accounts receivables | -3.87 Million | 183.86 Thousand | -21.46 Million | -27.41 Million | -30.08 Million |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | -22.93 Million | -23 Million | 15.07 Million | 38.78 Million | -530.04 Million |
Cash at beginning of period | 23.42 Million | 50.96 Million | 44.1 Million | 19.26 Million | - |
Cash at end of period | 27.11 Million | 23.42 Million | 50.96 Million | 44.1 Million | 19.26 Million |
Capital Expenditure | -1.47 Million | -1.11 Million | -658.32 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | 507.3 Million |
Net cash flow / Change in cash | 3.68 Million | -27.54 Million | 6.85 Million | 24.84 Million | 19.26 Million |
Free Cash Flow | 47.05 Million | 75.61 Million | 90.73 Million | 54.7 Million | -535.5 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 23.77 Million | 23.77 Million | 17.94 Million | 35.13 Million | 8.97 Million | 17.18 Million |
Depreciation & Amortization | 10.82 Million | 10.82 Million | 21.77 Million | 43.53 Million | 10.88 Million | 21.76 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 25.72 Million | 25.72 Million | -12.37 Million | -26.8 Million | -6.18 Million | -14.42 Million |
Other non-cash items | -7.64 Million | -7.64 Million | 42.9 Million | 87.61 Million | 3.91 Million | 44.71 Million |
Investing Cash Flow | -85.18 Thousand | -85.18 Thousand | -490.7 Thousand | -3.24 Million | -245.35 Thousand | -2.75 Million |
Investments in PPE | -170.36 Thousand | - | -420.4 Thousand | -1.47 Million | - | -1.05 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -87.6 Million | - | -70.29 Thousand | -1.76 Million | - | -1.69 Million |
Sales/Maturities of investments | 87.6 Million | - | - | - | - | - |
Other Investing Activities | -85.18 Thousand | -85.18 Thousand | -245.35 Thousand | -1.76 Million | -245.35 Thousand | -1.37 Million |
Financing Cash Flow | -16.4 Million | -16.4 Million | -26.68 Million | -41.6 Million | -15.69 Million | -14.92 Million |
Debt repayment | - | - | - | -1.57 Million | - | - |
Dividends payments | -13.34 Million | -13.34 Million | -26.68 Million | -40.02 Million | -13.34 Million | -13.34 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.05 Million | -3.05 Million | -2.35 Million | -20.71 Million | -2.35 Million | -8.79 Million |
Accounts receivables | -3.59 Million | -3.59 Million | 3.78 Million | -3.87 Million | 2.11 Million | -7.65 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 29.32 Million | 29.32 Million | -16.16 Million | -22.93 Million | -8.3 Million | -6.77 Million |
Cash at beginning of period | 27.11 Million | - | 23.8 Million | 23.42 Million | - | 23.42 Million |
Cash at end of period | 99.49 Million | 36.19 Million | 27.11 Million | 27.11 Million | 1.65 Million | 23.8 Million |
Capital Expenditure | -170.36 Thousand | - | -420.4 Thousand | -1.47 Million | - | -1.05 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 72.38 Million | 36.19 Million | 3.3 Million | 3.68 Million | 1.65 Million | 379.97 Thousand |
Free Cash Flow | 52.5 Million | 52.67 Million | 30.05 Million | 47.05 Million | 17.59 Million | 16.99 Million |
CAG
RILYM
SSAB-B
4LL
600979
PMEDF